The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph David Khoury, Éric Solary, Oussama Abla, Yassmine M. N. Akkari, Rita Alaggio, Jane F. Apperley, Rafael L. Bejar, Emilio Berti, Lambert Busque, John K. C. Chan, Weina Chen, Xueyan Chen, Wee Joo Chng, John Kim Choi, Isabel Colmenero, Sarah E. Coupland, Nicholas C.P. Cross, Daphne de Jong, M. Tarek Elghetany, Emiko Takahashi, Jean‐François Emile, Judith A. Ferry, Linda Fogelstrand, Michaëla Fontenay, Ulrich Germing, Sumeet Gujral, Torsten Haferlach, Claire N. Harrison, Jennelle C. Hodge, Shimin Hu, Joop H. Jansen, Rashmi Kanagal‐Shamanna, Hagop M. Kantarjian, Christian Peter Kratz, Xiaoqiu Li, Megan S. Lim, Keith R. Loeb, Sanam Loghavi, Andrea N. Marcogliese, Soheil Meshinchi, Phillip D. Michaels, Kikkeri N. Naresh, Yasodha Natkunam, Reza Nejati, German Ott, Eric Padron, Keyur Pravinchandra Patel, Nikhil V. Patkar, Jennifer Lee Picarsic, Uwe Platzbecker, Irene A.G. Roberts, Anna Schuh, William A. Sewell, Reiner Siebert, Prashant Ramesh Tembhare, Jeffrey W Tyner, Srđan Verstovšek, Wei Wang, Brent Lee Wood, Wenbin Xiao, Cecilia C.S. Yeung, Andreas Hochhaus
Leukemia · 2022 · 4,671 citationsOpen access
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Khoury, J. D., Solary, É., Abla, O., Akkari, Y. M. N., Alaggio, R., Apperley, J. F., Bejar, R. L., Berti, E., Busque, L., Chan, J. K. C., Chen, W., Chen, X., Chng, W. J., Choi, J. K., Colmenero, I., Coupland, S. E., Cross, N. C., Jong, D. de, Elghetany, M. T., … Hochhaus, A. (2022). The 5th edition of the world health organization classification of haematolymphoid tumours: Myeloid and Histiocytic/Dendritic neoplasms. Leukemia, 36(7), 1703–1719. https://doi.org/10.1038/s41375-022-01613-1
In text: (Khoury et al., 2022)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
The upcoming 5th edition of the World Health Organization (WHO) Classification of Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers arising in various organ systems within a single relational database. This paper summarizes the new WHO classification scheme for myeloid and histiocytic/dendritic neoplasms and provides an overview of the principles and rationale underpinning changes from the prior edition. The definition and diagnosis of disease types continues to be based on multiple clinicopathologic parameters, but with refinement of diagnostic criteria and emphasis on therapeutically and/or prognostically actionable biomarkers. While a genetic basis for defining diseases is sought where possible, the classification strives to keep practical worldwide applicability in perspective. The result is an enhanced, contemporary, evidence-based classification of myeloid and histiocytic/dendritic neoplasms, rooted in molecular biology and an organizational structure that permits future scalability as new discoveries continue to inexorably inform future editions.
Related papers
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia2016
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF12010
- IDH1 and IDH2 Mutations in Gliomas2009
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel2016
- Proposals for the Classification of the Acute Leukaemias F rench ‐A merican ‐B ritish (FAB) C o‐operative G roup1976
Metadata from OpenAlex (CC0). Citations are generated from the published record.